What's breaking now, across thousands of outlets.
Bell alleges he was assured the procedure would be 'relatively low-risk,' and would resolve his residual pain
We haven't written up this one. Toronto Sun has the full story — the link below goes straight to it.
Centene is expanding its CHOICE Arrangements benefits program to its employees in Ohio and Oklahoma in the 2027 plan year.
Tumors possess myriad mechanisms to ensure their survival even at the peril of the host. Now scientists are delving deeper into how cancer cells alter the metabolism of specific amino acids to support…
Sustainable packaging is only the beginning. What a medicine is made from—and how its ingredients are produced—matters just as much.
Discover the top stories from Oct. 10 to Oct. 16, 2026, including what COVID-19 variants scientists are currently tracking and how gray wolves are using active wildfires to hunt.
Molecular imaging with ⁶⁸Ga-HER2 PET/CT may provide an early, targeted measure of how well treatment is working in patients with HER2-positive breast cancer.
(Oleg Breslavtsev/Moment RF/Getty Images) Take control. Don't miss a story, subscribe here.
